John Chapman

Sr. Director, Commercial Financial Planning & Analysis at Taiho Oncology, Inc.

John Chapman has a diverse work experience spanning various roles within the finance field. John joined Taiho Oncology, Inc. in 2016 and held positions of increasing responsibility. John started as an Associate Director in Commercial Financial Planning & Analysis and was promoted to Director in 2019. Currently, they hold the position of Sr. Director in the same department. Before joining Taiho Oncology, Inc., John worked at Covance from 2011 to 2016. John served as a Senior Manager in Financial Planning & Analysis Business Partner and later transitioned to Senior Manager in Global IT Finance. Prior to Covance, John spent several years at Novo Nordisk, where they held roles such as Senior Financial Analyst, Project Manager, and Manager in Financial Analysis.

John Chapman attended Rider University, where they studied Management Sciences. The specific start and end years of their education were not provided. In addition to their degree, John Chapman has obtained several certifications from LinkedIn. These certifications include "Delegating Tasks," "Make the Move from Individual Contributor to Manager," "New Manager Foundations," and "Onboarding New Hires as a Manager." All of these certifications were obtained in May 2022.

Links

Previous companies

Novo Nordisk logo

Timeline

  • Sr. Director, Commercial Financial Planning & Analysis

    January, 2023 - present

  • Director, Commercial Financial Planning & Analysis

    January, 2019

  • Associate Director, Commercial Financial Planning & Analysis

    February, 2016